期刊文献+

小剂量阿卡波糖联合胰岛素治疗对2型糖尿病患者胰岛β细胞功能的影响 被引量:2

下载PDF
导出
摘要 目的探讨小剂量阿卡波糖联合胰岛素在2型糖尿病(T2DM)的应用价值。方法选定T2DM患者42例,分为单独用药与联合用药组各21例,测定两组在治疗后1个月(第一追踪点)及治疗后2年(第二追踪点)的静脉血浆血糖、胰岛素、C肽等指标,比较稳态模型的胰岛素抵抗指数(HOMA-IR和HOMA-β)。结果两组达到靶血糖值的时间、胰岛素用量及第二追踪点空腹C肽(FCP)、餐后2h C肽(2hCP)、空腹胰岛素(FIns)、餐后2h胰岛素(2hIns)、HOMA-IR、HOMA-β及体重指数(BMI)差异有显著性(P<0.01)。结论小剂量阿卡波糖与胰岛素联合应用,较单一应用胰岛素对T2DM患者胰岛β细胞功能有长远的有益影响。
出处 《右江民族医学院学报》 2006年第6期942-943,共2页 Journal of Youjiang Medical University for Nationalities
  • 相关文献

参考文献7

  • 1李霞,周智广,黄干,彭健,颜湘,王建平,杨琳.罗格列酮与胰岛素合用对LADA患者胰岛β细胞功能保护作用的初步观察[J].中国糖尿病杂志,2003,11(4):242-246. 被引量:63
  • 2谢晓敏,牛旭东,于丽萍,周海燕,张丽,李仁达,李玲,史静,侯庆宁.胰岛素联合文迪雅治疗对新发2型糖尿病患者β细胞功能的影响[J].宁夏医学杂志,2006,28(2):115-118. 被引量:1
  • 3Alberti KG,Zimmer PZ.Definition,diagnosis and classification of diabtes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabet Med,1998,15(7):539-553.
  • 4Yki-Jarvinen H.Pathogenesis of non-insulin-dependent diabetes mellitus[J].Lancet,1994,343(8889):91-95.
  • 5Kilpatrick ED,Robertson RP.Differentiation between glucose induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line[J].Diabtes,1998,47(4):606-611.
  • 6Mertes G.Safety and efficacy of acarbose in the treatment of Type 2 diabetes:dat from a 5-year surveillance study[J].Diabetes Res Clin Pract,2001,52(3):193-204.
  • 7Laube H,Linn TH.Heyen P.The effect of acarbose on insulin sensitivity and proinsulin in over weight subjects with impaired glucose to lerance[J].Exp Clin Endocrinol Diabetes,1998,106(3):231-233.

二级参考文献17

  • 1王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 2[1]Carlsson A, Sundkvist G, Groop L, et al. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab,2000,85:76-80.
  • 3[2]Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol, 2001, 169:453-459.
  • 4[4]Johansson BL, Brog K, Fernqvist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med, 2000, 17:181-189.
  • 5[5]Di Mario U, Dotta F. Modulation of antigen expression in relation to intervention strategies in type 1 diabetes. Diabete Metab Rev, 1993.245-249.
  • 6[6]Kobayashi T, Nakanishi K, Murase T , et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes, 1996,45:622-626.
  • 7[7]Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve β cells in slowly progressive insulin-dependent (type 1) diabetes mellitus. Ann NY Acad Sci, 2002, 958:117-130.
  • 8[8]Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev,2002,18:114-117.
  • 9Kahe SE.The importance of β cell failure in the development and progression of type 2 diabetes[J].J Clin Endocrinol Metab,2001,86:4047.
  • 10Albarrak AI,Luzio SD,Chassin LJ,et al.Association of glucose control with insulin sensitivity and pancreatic-cell responsiveness in newly presenting type 2 diabetes[J].J Clin Endocrinol Metab,2002,87:198-203.

共引文献62

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部